Patient Engagement Solutions Market 2026
The Patient Engagement Solutions Market was valued at in and is anticipated to reach by , at a CAGR of 0.191 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Patient Engagement Solutions Market.
This report delivers a comprehensive overview of the Patient Engagement Solutions Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Patient Engagement Solutions Market. The Patient Engagement Solutions Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Patient Engagement Solutions Market Scope:
Key Players
This report delivers a comprehensive overview of the Patient Engagement Solutions Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Patient Engagement Solutions Market. The Patient Engagement Solutions Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Patient Engagement Solutions Market.
This report delivers a comprehensive overview of the Patient Engagement Solutions Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Patient Engagement Solutions Market. The Patient Engagement Solutions Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Patient Engagement Solutions Market Scope:
Key Players
- Allscripts Healthcare Solutions, Inc
- Athenahealth, Inc
- Cerner Corporation
- McKesson Corporation
- Phytel, Inc
- Orion Health Ltd
- Lincor Solutions Ltd
- GetWellNetwork, Inc
- YourCareUniverse, Inc
- MEDecision, Inc
This report delivers a comprehensive overview of the Patient Engagement Solutions Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Patient Engagement Solutions Market. The Patient Engagement Solutions Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Product component
3.2. Market Snippet by Mode of Delivery
3.3. Market Snippet by Application
3.4. Market Snippet by End-user
3.5. Market Snippet by Therapeutic Area
4. DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rise in the aging population
4.1.1.2. The increasing burden of chronic diseases
4.1.1.3. The rise in the focus of patients on self-managing their care
4.1.2. Restraints
4.1.2.1. Concerns related to the security of patient data
4.1.2.2. The lack of interoperability
4.1.3. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
6. BY PRODUCT COMPONENT
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
6.3. Market Attractiveness Index, By Product component
6.3.1. Hardware *
6.3.1.1. Introduction
6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
6.3.2. Software
6.3.2.1. Standalone Solutions
6.3.2.2. Integrated Solutions
6.3.3. Services
6.3.3.1. Consulting Services
6.3.3.2. Implementation Services
6.3.3.3. Training & Education Services
6.3.3.4. Post-sale & Maintenance Services
6.3.3.5. Advertising Services
6.3.3.6. Enrollment Services
7. BY MODE OF DELIVERY
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
7.3. Market Attractiveness Index, By Mode of Delivery
7.3.1. On-Premise *
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
7.3.2. Web-based
7.3.3. Cloud-based
8. BY APPLICATION
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.3. Market Attractiveness Index, By Application
8.3.1. Health Management *
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
8.3.2. Social and Behavioral Management
8.3.3. Home Health Management
8.3.4. Financial Health Management
9. BY END-USER
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.3. Market Attractiveness Index, By End-user
9.3.1. Individual Users *
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
9.3.2. Providers
9.3.2.1. Hospitals
9.3.2.2. Physicians
9.3.3. Payers
9.3.3.1. Private
9.3.3.2. Government
9.3.4. Other End Users
10. BY THERAPEUTIC AREA
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
10.3. Market Attractiveness Index, By Therapeutic Area
10.3.1. Chronic Diseases *
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
10.3.1.3. Diabetes
10.3.1.4. Cardiovascular Disease
10.3.1.5. Obesity (Weight Loss Management)
10.3.1.6. Other Chronic Diseases
10.3.2. Women's Health
10.3.3. Fitness
10.3.4. Other Therapeutic Areas
11. BY REGION
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. The U.S.
11.4.8.2. Canada
11.4.8.3. Mexico
11.5. Europe
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. Germany
11.5.8.2. U.K.
11.5.8.3. France
11.5.8.4. Italy
11.5.8.5. Spain
11.5.8.6. Rest of Europe
11.6. South America
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.6.8.1. Brazil
11.6.8.2. Argentina
11.6.8.3. Rest of South America
11.7. Asia-Pacific
11.7.1. Introduction
11.7.2. Key Region-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.7.8.1. China
11.7.8.2. India
11.7.8.3. Japan
11.7.8.4. Australia
11.7.8.5. Rest of Asia Pacific
11.8. Middle East and Africa
11.8.1. Introduction
11.8.2. Key Region-Specific Dynamics
11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
12. GLOBAL MARKET COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Comparative Product component Portfolio Analysis
12.3. Market Positioning/Share Analysis
12.4. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Allscripts Healthcare Solutions, Inc*
13.1.1. Company Overview
13.1.2. Product component Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Athenahealth, Inc
13.3. Cerner Corporation
13.4. McKesson Corporation
13.5. Phytel, Inc
13.6. Orion Health Ltd
13.7. Lincor Solutions Ltd
13.8. GetWellNetwork, Inc
13.9. YourCareUniverse, Inc
13.10. MEDecision, Inc
14. PREMIUM INSIGHTS
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Product component
3.2. Market Snippet by Mode of Delivery
3.3. Market Snippet by Application
3.4. Market Snippet by End-user
3.5. Market Snippet by Therapeutic Area
4. DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rise in the aging population
4.1.1.2. The increasing burden of chronic diseases
4.1.1.3. The rise in the focus of patients on self-managing their care
4.1.2. Restraints
4.1.2.1. Concerns related to the security of patient data
4.1.2.2. The lack of interoperability
4.1.3. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
6. BY PRODUCT COMPONENT
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
6.3. Market Attractiveness Index, By Product component
6.3.1. Hardware *
6.3.1.1. Introduction
6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
6.3.2. Software
6.3.2.1. Standalone Solutions
6.3.2.2. Integrated Solutions
6.3.3. Services
6.3.3.1. Consulting Services
6.3.3.2. Implementation Services
6.3.3.3. Training & Education Services
6.3.3.4. Post-sale & Maintenance Services
6.3.3.5. Advertising Services
6.3.3.6. Enrollment Services
7. BY MODE OF DELIVERY
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
7.3. Market Attractiveness Index, By Mode of Delivery
7.3.1. On-Premise *
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
7.3.2. Web-based
7.3.3. Cloud-based
8. BY APPLICATION
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.3. Market Attractiveness Index, By Application
8.3.1. Health Management *
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
8.3.2. Social and Behavioral Management
8.3.3. Home Health Management
8.3.4. Financial Health Management
9. BY END-USER
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.3. Market Attractiveness Index, By End-user
9.3.1. Individual Users *
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
9.3.2. Providers
9.3.2.1. Hospitals
9.3.2.2. Physicians
9.3.3. Payers
9.3.3.1. Private
9.3.3.2. Government
9.3.4. Other End Users
10. BY THERAPEUTIC AREA
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
10.3. Market Attractiveness Index, By Therapeutic Area
10.3.1. Chronic Diseases *
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
10.3.1.3. Diabetes
10.3.1.4. Cardiovascular Disease
10.3.1.5. Obesity (Weight Loss Management)
10.3.1.6. Other Chronic Diseases
10.3.2. Women's Health
10.3.3. Fitness
10.3.4. Other Therapeutic Areas
11. BY REGION
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. The U.S.
11.4.8.2. Canada
11.4.8.3. Mexico
11.5. Europe
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. Germany
11.5.8.2. U.K.
11.5.8.3. France
11.5.8.4. Italy
11.5.8.5. Spain
11.5.8.6. Rest of Europe
11.6. South America
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.6.8.1. Brazil
11.6.8.2. Argentina
11.6.8.3. Rest of South America
11.7. Asia-Pacific
11.7.1. Introduction
11.7.2. Key Region-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.7.8.1. China
11.7.8.2. India
11.7.8.3. Japan
11.7.8.4. Australia
11.7.8.5. Rest of Asia Pacific
11.8. Middle East and Africa
11.8.1. Introduction
11.8.2. Key Region-Specific Dynamics
11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
12. GLOBAL MARKET COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Comparative Product component Portfolio Analysis
12.3. Market Positioning/Share Analysis
12.4. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Allscripts Healthcare Solutions, Inc*
13.1.1. Company Overview
13.1.2. Product component Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Athenahealth, Inc
13.3. Cerner Corporation
13.4. McKesson Corporation
13.5. Phytel, Inc
13.6. Orion Health Ltd
13.7. Lincor Solutions Ltd
13.8. GetWellNetwork, Inc
13.9. YourCareUniverse, Inc
13.10. MEDecision, Inc
14. PREMIUM INSIGHTS
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
